SCHEMBL31350552

SCHEMBL31350552

N#CNc1ncc(C(F)(F)F)cc1C#N

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
GAA P10253 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 3/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
HTT P42858 1/20 0.33
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16649161 0.75 CYP11B1 (0.46) SMN1; SMN2GAATDP1CYP11B1CYP11B2
SCHEMBL30055347 0.74 ALDH1A1 (0.49) SMN1; SMN2GAATDP1CYP11B1CYP11B2
SCHEMBL31350596 0.74 OPRK1 (0.36) SMN1; SMN2GAATDP1CYP11B1CYP11B2
SCHEMBL4766176 0.74 CYP11B1 (0.42) SMN1; SMN2GAACYP11B1CYP11B2ALDH1A1
SCHEMBL2634852 0.74 ALDH1A1 (0.49) SMN1; SMN2GAATDP1CYP11B1CYP11B2
SCHEMBL16139574 0.74 CYP11B1 (0.42) SMN1; SMN2GAACYP11B1CYP11B2ALDH1A1
SCHEMBL31350683 0.74 OPRK1 (0.36) SMN1; SMN2GAATDP1CYP11B1CYP11B2
SCHEMBL582977 0.74 ALDH1A1 (0.46) SMN1; SMN2GAACYP11B1CYP11B2ALDH1A1
SCHEMBL31350832 0.74 CHEK1 (0.37) SMN1; SMN2TDP1CYP11B1CYP11B2ALDH1A1
SCHEMBL24147640 0.70 AGBL2 (0.40) SMN1; SMN2GAATDP1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743462-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2026-05-20 EP disclosed
WO-2025012643-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2025-01-16 WO disclosed